Followers | 7 |
Posts | 177 |
Boards Moderated | 0 |
Alias Born | 05/05/2013 |
Tuesday, April 01, 2014 2:49:48 AM
Plus, Purdue has NOT had theirs even approved yet. Zogenix most likely will have their drug approved at same time.
Do you have any idea the amount of lawsuits Zogenix is about to win? How many doctors should lose their ability to practice medicine because they can't even use a simple drug comparison chart?
This company is fine. Zohydro is pennies compared to Relday. Relday is finishing Phase 1 clinical trials and will be set to launch in 2016.
FDA made Zohydro go through thorough 18 month review process that has been repetitively and publicly been reaffirmed. Zogenix has license to the IP around Zohydro, AND the abuse deterrent formulation in development. IP alone is worth tens of millions
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM